Coronary drug-eluting stent market to grow 4% in India till 2033: Report
India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.
HQ Team April 3, 2024: A smartphone can measure the glucose levels of diabetic patients, diagnose disease and detect environmental toxins, with the.
HQ Team November 28, 2023: The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization.